Site Map: Patient

The site map below provides quick access to all site content by clicking on a link to access that page. The Healthcare Professionals section is for US Healthcare Professionals only.

Patients

About Hodgkin's Lymphoma

About Matulane®

Prescribing Information

Reimbursement Information

Patient Assistance Program

Back To Top

Site Map: Healthcare Professional

The site map below provides quick access to all site content by clicking on a link to access that page. The Healthcare Professionals section is for U.S. Healthcare Professionals only.

Health Care Professionals

Treatment Overview

Prescribing Information

Professional Resources

Reimbursement Information

Patient Assistance Program

About Hodgkin's Lymphoma

Back To Top

Important Safety Information

WARNING
It is recommended that MATULANE be given only by or under the supervision of a physician experienced in the use of potent antineoplastic drugs. Adequate clinical and laboratory facilities should be available to patients for proper monitoring of treatment.

Matulane is contraindicated in patients with known hypersensitivity to the drug or inadequate marrow reserve as demonstrated by bone marrow aspiration. Due consideration of this possible state should be given to each patient who has leukopenia, thrombocytopenia, or anemia.

Matulane in combination therapy is a potent chemotherapeutic agent. Before prescribing Matulane, the sections in the Prescribing Information concerning usage in pregnancy, occurrence of secondary cancers, monitoring required in liver and kidney disease, hematologic effects, CNS effects, and potentiation associated with alcohol and MAO inhibitors should be carefully evaluated.

Please see full Prescribing Information for Matulane indications and usage, contraindications, and warnings including boxed WARNINGS, precautions, and adverse reactions.